<DOC>
	<DOCNO>NCT00000722</DOCNO>
	<brief_summary>To compare use pentamidine aerosol ( inhaled mist ) standard intravenous method administration patient AIDS relate Pneumocystis carinii pneumonia ( PCP ) , measure amount pentamidine aerosol actually reach lung , see close clinical observation safer effective drug therapy prevention PCP recurrence . To compare efficiency 2 nebulizer - Respirgard II nebulizer Cadema Aerotech II nebulizer . Aerosolized pentamidine effective intravenous pentamidine treat PCP animal . More pentamidine reach lung less found liver kidney pentamidine give aerosol intravenous injection . This suggest toxicity pentamidine may less give aerosol give intravenous route .</brief_summary>
	<brief_title>Aerosols Treatment Pneumocystis Pneumonia : A Pilot Study Quantitating Deposition Aerosolized Pentamidine Delivered ACTG 040 Comparing Its Toxicity With Parenteral Pentamidine Therapy</brief_title>
	<detailed_description>Aerosolized pentamidine effective intravenous pentamidine treat PCP animal . More pentamidine reach lung less found liver kidney pentamidine give aerosol intravenous injection . This suggest toxicity pentamidine may less give aerosol give intravenous route . Patients inhale one dose radiolabeled aerosol contain pentamidine , image lung take immediately 24 hour later determine amount pentamidine reach various area lung . Patients undergo bronchoalveolar lavage ( BAL ) order recover PCP organism lung corroborate diagnosis PCP . If PCP organisms detect , patient randomly assign aerosolized intravenous pentamidine treat 21 day . Patients take pentamidine aerosol repeat radiolabeled aerosol study day 9 . The BAL repeat end therapy patient . If patient improve within 9 day , switch another therapy . After completion therapy , patient give option prophylactic therapy , i.e. , dose medication prevent reinfection , PCP . All patient carefully assess every 4 week 6 month whether begin prophylactic therapy . Zidovudine ( AZT ) may take 21-day trial increase risk side effect , resume PCP therapy complete .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Inclusion Criteria Prior Medication : Allowed : Prophylaxis Pneumocystis carinii pneumonia ( PCP ) ; zidovudine . Unequivocal diagnosis Pneumocystis carinii pneumonia ( PCP ) establish morphological confirmation three typical Pneumocystis carinii organism bronchoalveolar lavage fluid , obtain immediately follow initial inhalation radiolabeled aerosol . Resting ( Aa ) DO2 &lt; 30 torr room air rest ( Aa ) DO2 = &lt; 55 torr room air serious intolerance trimethoprim / sulfamethoxazole ( TMP / SMX ) , define one following : Platelets &lt; 50000 platelets/mm3 absolute neutrophil count ( polys plus band ) = &lt; 500 cells/mm3 least two occasion = &gt; 12 hour apart . Blistering rash , mucosal involvement , generalize maculopapular eruption , intolerable pruritus . Transaminase &gt; 5 x ULN = &gt; 300 IU baseline abnormal . Daily temperature = &gt; 103 degree F begin 5th day treatment persist least 3 day responsive antipyretic therapy , discernible cause . Any severe lifethreatening adverse reaction TMP / SMX , investigator 's opinion , make continued recurrent treatment TMP / SMX inadvisable ( approved casebycase basis NIAID clinical monitor ) . Exclusion Criteria Coexisting Condition : Patients follow condition disease exclude : Dyspnea , cough , bronchospasm , reason cause inability cooperate aerosol administration . History major adverse reaction pentamidine . Patients follow condition disease exclude : Dyspnea , cough , bronchospasm , reason cause inability cooperate aerosol administration . History major adverse reaction pentamidine . Prior Medication : Excluded : Other antiprotozoal regimen . Excluded within 14 day entry : Systemic steroid &gt; adrenal replacement dos</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Injections , Intravenous</keyword>
	<keyword>Lung</keyword>
	<keyword>Administration , Inhalation</keyword>
	<keyword>Aerosols</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>